Jaguar Health Reports Q1 2024 Financial Results; Investor Webcast 8:30 a.m. Eastern Today #JAGX
Jaguar Health
Pharmaceutical Manufacturing
San Francisco, California 4,209 followers
Bringing Plant-based Medicines to Life™ | Investor News: https://jaguarhealth.gcs-web.com
About us
Jaguar Health (NASDAQ: JAGX) (“Jaguar”) is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Napo Pharmaceuticals, a Jaguar company, focuses on developing and commercializing proprietary human pharmaceuticals from plants harvested responsibly from rainforest areas. Jaguar is the majority shareholder of Napo Therapeutics S.p.A., a corporation established by Jaguar in Italy in 2021 that focuses on expanding crofelemer access in Europe. Jaguar Animal Health is a tradename of Jaguar Health. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health, focuses on developing novel, natural prescription medicines derived from plants for mental health indications including attention-deficit/hyperactivity disorder (ADHD) in adults. For more information about Jaguar, please visit https://jaguar.health. For more information about Napo Pharmaceuticals, visit www.napopharma.com. For more information about Napo Therapeutics, visit napotherapeutics.com. For more information about Magdalena Biosciences, visit magdalenabiosciences.com. To read our full social media policy, please visit https://jaguar.health/social-media-policy
- Website
-
https://jaguar.health
External link for Jaguar Health
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- San Francisco, California
- Type
- Public Company
- Founded
- 2013
- Specialties
- Gastrointestinal Health, HIV, Cancer Supportive Care, AIDS, Canine Health, Rare Diseases, and Orphan Diseases
Locations
-
Primary
200 Pine St
Suite 400
San Francisco, California 94104, US
Employees at Jaguar Health
Updates
-
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates #JAGX
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates | Jaguar Health, Inc.
jaguarhealth.gcs-web.com
-
Jaguar Health Announces Submission of Clinical Trial Applications for the Rare Disease Indications Microvillus Inclusion Disease and Short Bowel Syndrome in Europe #JAGX
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe | Jaguar Health, Inc.
jaguarhealth.gcs-web.com
-
Jaguar Health to Hold Q1 2024 Earnings Webcast Tuesday, May 14 at 8:30 AM Eastern #JAGX
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates | Jaguar Health, Inc.
jaguarhealth.gcs-web.com